MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Zimmerli D, Brambillasca CS, Talens F, Bhin J, Linstra R, Romanens L, Bhattacharya A, Joosten SEP, Da Silva AM, Padrao N, Wellenstein MD, Kersten K, de Boo M, Roorda M, Henneman L, de Bruijn R, Annunziato S, van der Burg E, Drenth AP, Lutz C, Endres T, van de Ven M, Eilers M, Wessels L, de Visser KE, Zwart W, Fehrmann RSN, van Vugt MATM, Jonkers J.
Zimmerli D, et al. Among authors: van de ven m, van vugt matm, van der burg e.
Nat Commun. 2022 Nov 2;13(1):6579. doi: 10.1038/s41467-022-34000-6.
Nat Commun. 2022.
PMID: 36323660
Free PMC article.